IgLON5 autoimmunity secondary to immune checkpoint inhibitor. Itoh C, Swart G, St Louis E, Gandhi M, et al. J Neuroimmunol 2024;399:578516.

Read + Share

Amedeo Smart

Independent Medical Education

Itoh C, Swart G, St Louis E, Gandhi M, et al. IgLON5 autoimmunity secondary to immune checkpoint inhibitor. J Neuroimmunol 2024;399:578516.
PMID: 39709726